earnings
confidence high
sentiment negative
materiality 0.75
Pediatrix Q3 GAAP EPS $0.26, Adjusted EPS $0.32; FY guidance $200-210M
Pediatrix Medical Group, Inc.
2023-Q3 EPS reported
$0.77
revenue$1,498,197,000
- Q3 GAAP EPS $0.26 vs $0.35 YoY; Adjusted EPS $0.32 vs $0.40.
- Net revenue $506.6M (+3.4% YoY) but same-unit patient volume declined 1.2%.
- Adjusted EBITDA $50.4M, down 13.5% from $58.3M; practice costs rose to $368.4M.
- FY2023 Adjusted EBITDA guidance $200-210M; first nine months $149.6M implies soft Q4.
- Terminated R1 RCM contract effective Dec 15, 2023; plans hybrid revenue cycle model.